Overview

Bioequivalence of Ezetimibe Tablets in Healthy Subjects

Status:
Recruiting
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
According to the relevant provisions of bioequivalence test, ezetimibe Tablets (test preparation, T, 10mg / tablet) provided by China Resources Saike Pharmaceutical Co., Ltd. were compared with Ezetrol ® (reference preparation, R, 10mg / tablet) produced by MSD Pharma (Singapore) Pte. Ltd. to evaluate the bioequivalence of single dose in healthy subjects under fasting and fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Cao Yu
Treatments:
Ezetimibe